For more than a quarter of a century, a dedicated cohort of researchers at Northwestern Medicine has been investigating a…
Read More
From Coal Dust to Clean Energy: How Cumberland is Repurposing Abandoned Mines for a Sustainable Future
The village of Cumberland, British Columbia, was once defined by the rhythmic clatter of coal cars and the soot-heavy air…
Read More
The Integration of Artificial Intelligence into Radiology and Clinical Labs: A Transformative, Yet Contentious, Frontier
The head of NYC Health + Hospitals, the largest public healthcare system in the United States, has posited that artificial…
Read More
Biopharma Leaders Urge Dr. Richard Pazdur to Lead FDA Amidst Crisis of Confidence
The leadership void at the U.S. Food and Drug Administration (FDA) has prompted a significant groundswell of support from the…
Read More
After flight training, the brain began treating wings more like real limbs
The remarkable plasticity of the human brain has once again been demonstrated through a groundbreaking study where participants, after undergoing…
Read More
Brazilian Tree Compounds Show Potent Multi-Target Activity Against COVID-19 Virus
Researchers have identified a group of natural compounds from a Brazilian tree that show promising activity against the virus responsible…
Read More
TWiV 1290: Clinical update with Dr. Daniel Griffin | Microbe TV
In his latest clinical update, Dr. Daniel Griffin, in conversation with Vincent Racaniello on the podcast "This Week in Virology"…
Read More
UCSF Researchers Discover Lungs as a Major Site of Blood Production and Source of Hematopoietic Stem Cells
The human circulatory system is a marvel of constant biological regeneration, requiring the daily production of approximately 200 billion new…
Read More
Groundbreaking Study Reveals Psilocybin Reduces Aggression and Activity in Mangrove Rivulus Fish, Opening New Avenues for Neuropsychiatric Research
A pioneering study has demonstrated that psilocybin, the psychoactive compound found in "magic mushrooms," can significantly reduce aggression and activity…
Read More
Lilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. Can its deal spree avoid Pfizer’s fate?
Eli Lilly and Company, currently buoyed by the explosive success of its GLP-1 franchise, has announced its intent to acquire…
Read MoreYOU MAY HAVE MISSED
